Search research articles
Contact Us
Filters
Showing results (111-120 of 131) with videos related to
Page
of 14
Sort By:
Transplantation and Cellular Therapy
|
March 16, 2026
Ferritin as a pre-transplant biomarker for post-transplant outcomes in allogeneic stem cell transplantation using post-transplant cyclophosphamide
Sergio Rodriguez-Rodriguez, Caden Chiarello, Nihar Desai, et al.
Transplantation Direct
|
January 13, 2025
Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation: Does Speeding Up Neutrophil Engraftment Make a Difference?
Ahmed Alnughmush, Ayman Sayyed, Mats Remberger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2011
Troponin I and C-reactive protein are commonly detected in patients with breast cancer treated with dose-dense chemotherapy incorporating trastuzumab and lapatinib
Patrick G Morris, Carol Chen, Richard Steingart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 11, 2009
Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction
Patrick G Morris, Maura Dickler, Heather L McArthur, et al.
Recent Patents on Cardiovascular Drug Discovery
|
May 24, 2011
The role of minocycline in ischemia-reperfusion injury: a comprehensive review of an old drug with new implications
Berkin O Ulgen, Matthew G Field, Waqas Qureshi, et al.
The American Journal of Cardiology
|
July 2, 2008
Amino acid supplementation differentially modulates STAT1 and STAT3 activation in the myocardium exposed to ischemia/reperfusion injury
Tiziano M Scarabelli, Paul A Townsend, Carol Chen Scarabelli, et al.
European Journal of Haematology
|
June 16, 2024
Impact of cytomegalovirus (CMV) seroconversion pre-allogeneic hematopoietic cell transplantation on posttransplant outcomes
Ayman Sayyed, Leeann Wilson, Vered Stavi, et al.
Transplantation and Cellular Therapy
|
January 28, 2024
Outcomes of Antithymocyte Globulin-Post-Transplantation Cyclophosphamide-Cyclosporine-Based versus Antithymocyte Globulin-Based Prophylaxis for 10/10 HLA-Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
Maria Queralt Salas, Tommy Alfaro-Moya, Eshetu G Atenafu, et al.
Plos One
|
August 10, 2016
Del1 Knockout Mice Developed More Severe Osteoarthritis Associated with Increased Susceptibility of Chondrocytes to Apoptosis
Zhen Wang, Misha C Tran, Namrata J Bhatia, et al.
Transplantation and Cellular Therapy
|
October 8, 2025
Size Does Not Always Matter: Limited Impact of Donor-recipient Weight Difference on Outcomes of Adult Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplantation
Caden Chiarello, Sihath Singhabahu, Mats Remberger, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 131) with videos related to
Sort By:
Page
of 14
Transplantation and Cellular Therapy
|
March 16, 2026
Ferritin as a pre-transplant biomarker for post-transplant outcomes in allogeneic stem cell transplantation using post-transplant cyclophosphamide
Sergio Rodriguez-Rodriguez, Caden Chiarello, Nihar Desai, et al.
Transplantation Direct
|
January 13, 2025
Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation: Does Speeding Up Neutrophil Engraftment Make a Difference?
Ahmed Alnughmush, Ayman Sayyed, Mats Remberger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2011
Troponin I and C-reactive protein are commonly detected in patients with breast cancer treated with dose-dense chemotherapy incorporating trastuzumab and lapatinib
Patrick G Morris, Carol Chen, Richard Steingart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 11, 2009
Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction
Patrick G Morris, Maura Dickler, Heather L McArthur, et al.
Recent Patents on Cardiovascular Drug Discovery
|
May 24, 2011
The role of minocycline in ischemia-reperfusion injury: a comprehensive review of an old drug with new implications
Berkin O Ulgen, Matthew G Field, Waqas Qureshi, et al.
The American Journal of Cardiology
|
July 2, 2008
Amino acid supplementation differentially modulates STAT1 and STAT3 activation in the myocardium exposed to ischemia/reperfusion injury
Tiziano M Scarabelli, Paul A Townsend, Carol Chen Scarabelli, et al.
European Journal of Haematology
|
June 16, 2024
Impact of cytomegalovirus (CMV) seroconversion pre-allogeneic hematopoietic cell transplantation on posttransplant outcomes
Ayman Sayyed, Leeann Wilson, Vered Stavi, et al.
Transplantation and Cellular Therapy
|
January 28, 2024
Outcomes of Antithymocyte Globulin-Post-Transplantation Cyclophosphamide-Cyclosporine-Based versus Antithymocyte Globulin-Based Prophylaxis for 10/10 HLA-Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
Maria Queralt Salas, Tommy Alfaro-Moya, Eshetu G Atenafu, et al.
Plos One
|
August 10, 2016
Del1 Knockout Mice Developed More Severe Osteoarthritis Associated with Increased Susceptibility of Chondrocytes to Apoptosis
Zhen Wang, Misha C Tran, Namrata J Bhatia, et al.
Transplantation and Cellular Therapy
|
October 8, 2025
Size Does Not Always Matter: Limited Impact of Donor-recipient Weight Difference on Outcomes of Adult Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplantation
Caden Chiarello, Sihath Singhabahu, Mats Remberger, et al.
Page
of 14